|
|
|
市場調査レポート
世界の核医学装置市場：2009年
Global Markets for Nuclear Medicine Systems 2009
|
Abstract
The global market for nuclear medicine systems is composed of sales of
positron emission tomography/computed tomography (PET/CT) and single photon
emission computed tomography (SPECT) systems. In 2008, revenues in this market
declined sharply due to the onset of the global economic crisis as well as
reduced demand in the US, where the market is mature and existing systems are
not being used to capacity. Revenues in all three regions in this market will
continue to suffer in 2009 because of the economic crisis, government
restrictions in China, market maturity in western countries, and concerns over
low reimbursement rates. As the crisis recedes in 2010, however, the market
will stabilize, driven by replacement sales, increased PET/CT procedure
volumes- encouraged by benefits of PET/CT scanning in oncology- and adoption
of more expensive hybrid SPECT/CT systems- favored by facilities because of
their richer feature set. Despite this upturn, the global market for nuclear
medicine systems will experience a slight overall decrease over the forecast
period.
Table of Contents
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 GLOBAL NUCLEAR MEDICINE SYSTEM MARKET
- 1.1 Market Overview
- 1.2 Market Analysis
- 1.2.1 Economic Assumptions for the Forecast Period
- 1.2.2 Market Definition
- 1.2.3 Market Forecast
- 1.2.3.1 US Nuclear Medicine System Market
- 1.2.3.2 European Nuclear Medicine System Market
- 1.2.3.3 Chinese Nuclear Medicine System Market
- 1.2.4 Market Drivers and Limiters
- 1.2.4.1 Market Drivers
- 1.2.4.2 Market Limiters
- 1.3 Competitive Analysis
2.0 US NUCLEAR MEDICINE SYSTEM MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Market Definition
- 2.2.2 Procedures
- 2.2.3 Market Forecast
- 2.2.3.1 PET/CT System Market
- 2.2.3.2 SPECT System Market
- Stand-Alone SPECT System Market
- Hybrid SPECT/CT System Market
- Dedicated Cardiac Camera Market
- 2.2.3.3 Installed Base
- 2.2.4 Market Drivers and Limiters
- 2.2.4.1 Market Drivers
- 2.2.4.2 Market Li+miters
- 2.3 Competitive Analysis
- 2.3.1 Market Shares
- 2.3.2 Competitor Discussions (in Alphabetical Order)
- Digirad
- GE Healthcare
- Philips Healthcare
- Siemens Healthcare
- Other
3.0 EUROPEAN NUCLEAR MEDICINE SYSTEM MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Market Definition
- 3.2.2 Market Forecast
- 3.2.2.1 PET/CT System Market
- 3.2.2.2 SPECT System Market
- Hybrid SPECT/CT System Market
- Stand-Alone SPECT System Market
- 3.2.3 Market Drivers and Limiters
- 3.2.3.1 Market Drivers
- 3.2.3.2 Market Limiters
- 3.3 Competitive Analysis
- 3.3.1 Market Shares
- 3.3.2 Competitor Discussions (in Alphabetical Order)
- GE Healthcare
- Philips Healthcare
- Siemens Healthcare
4.0 CHINESE NUCLEAR MEDICINE SYSTEM MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Market Definition
- 4.2.2 Market Forecast
- 4.2.2.1 PET/CT System Market
- 4.2.2.2 SPECT System Market
- Stand-Alone SPECT System Market
- Hybrid SPECT/CT System Market
- 4.2.2.3 Installed Base
- 4.2.3 Market Drivers and Limiters
- 4.2.3.1 Market Drivers
- 4.2.3.2 Market Limiters
- 4.3 Competitive Analysis
- 4.3.1 Market Shares
- 4.3.2 Competitor Discussions (in Alphabetical Order)
- GE Healthcare
- Philips Healthcare
- Siemens Healthcare
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: SUPPLEMENTAL EXHIBITS
List of Exhibits
EXECUTIVE SUMMARY
- Exhibit 1: Nuclear Medicine System Market, Global (US$), 2007- 2013
- Exhibit 2: Nuclear Medicine System Market, by Segment, US (US$), 2007- 2013
- Exhibit 3: Nuclear Medicine System Market, by Country, Europe (US$), 2007-
2013
- Exhibit 4: Nuclear Medicine System Market, by Segment, China (US$), 2007-
2013
- Exhibit 5: Leading Competitors in the Nuclear Medicine System Market,
Global, 2008
METHODOLOGY
- Exhibit 6: Currency Exchange Rates, 2008
- CHAPTER 1: GLOBAL NUCLEAR MEDICINE SYSTEM MARKET
- Exhibit 7: Nuclear Medicine System Market, Global (US$), 2007- 2013
- Exhibit 8: Nuclear Medicine System Market Segmentation, by Country,
Global, 2007- 2013
- Exhibit 9: Nuclear Medicine System Market, by Country, Global (US$), 2007-
2013
- Exhibit 10: Drivers and Limiters of the Nuclear Medicine System Market,
Global
- Exhibit 11: Leading Competitors in the Nuclear Medicine System Market, by
Country, as a % of Total, Global, 2008
Chapter 2: US NUCLEAR MEDICINE SYSTEM MARKET
- Exhibit 12: Nuclear Medicine System Market, US (US$), 2007- 2013
- Exhibit 13: Nuclear Medicine Procedures, by Segment, US, 2007- 2013
- Exhibit 14: Nuclear Medicine System Market, by Segment, US (US$), 2007-
2013
- Exhibit 15: PET/CT System Market, US (US$), 2007- 2013
- Exhibit 16: SPECT System Market, by Segment, US (US$), 2007- 2013
- Exhibit 17: SPECT System Market Growth, by Segment, US, 2008- 2013
- Exhibit 18: Nuclear Medicine System Installed Base, by Segment, US, 2007-
2013
- Exhibit 19: Drivers and Limiters of the Nuclear Medicine System Market, US
- Exhibit 20: Leading Competitors in the Nuclear Medicine System Market, by
Segment, as a % of Total, US, 2008
Chapter 3: EUROPEAN NUCLEAR MEDICINE SYSTEM MARKET
- Exhibit 21: Nuclear Medicine System Market, Europe (US$), 2007- 2013
- Exhibit 22: Nuclear Medicine System Market, by Segment and Country, Europe
(US$), 2007- 2013
- Exhibit 23: Nuclear Medicine System Market, by Segment and Country, Europe
(- and -), 2007- 2013
- Exhibit 24: Nuclear Medicine System Market Growth, by Segment and Country,
Europe, 2008- 2013
- Exhibit 25: PET/CT System Market, by Country, Europe (US$), 2007- 2013
- Exhibit 26: PET/CT System Market, by Country, Europe (- and -), 2007- 2013
- Exhibit 27: PET/CT System Market Growth, by Country, Europe, 2008- 2013
- Exhibit 28: SPECT System Market, by Country, Europe (US$), 2007- 2013
- Exhibit 29: SPECT System Market, by Country, Europe (- and -), 2007- 2013
- Exhibit 30: SPECT System Market Growth, by Country, Europe, 2008- 2013
- Exhibit 31: Hybrid SPECT/CT System Market, by Country, Europe (US$), 2007-
2013
- Exhibit 32: Hybrid SPECT/CT System Market, by Country, Europe (- and -),
2007- 2013
- Exhibit 33: Hybrid SPECT/CT System Market Growth, by Country, Europe,
2008- 2013
- Exhibit 34: Stand-Alone SPECT System Market, by Country, Europe (US$),
2007- 2013
- Exhibit 35: Stand-Alone SPECT System Market, by Country, Europe (- and
-), 2007- 2013
- Exhibit 36: Stand-Alone SPECT System Market Growth, by Country, Europe,
2008- 2013
- Exhibit 37: Drivers and Limiters of the Nuclear Medicine System Market,
Europe
- Exhibit 38: Leading Competitors in the Nuclear Medicine System Market, by
Country, as a % of Total, Europe, 2008
- Exhibit 39: Leading Competitors in the PET/CT System Market, by Country,
as a % of Total, Europe, 2008
- Exhibit 40: Leading Competitors in the SPECT System Market, by Country, as
a % of Total, Europe, 2008
Chapter 4: CHINESE NUCLEAR MEDICINE SYSTEM MARKET
- Exhibit 41: Nuclear Medicine System Market, China (US$), 2007- 2013
- Exhibit 42: Nuclear Medicine System Market, by Segment, China (US$ and
CNY), 2007- 2013
- Exhibit 43: PET/CT System Market, China (US$ and CNY), 2007- 2013
- Exhibit 44: SPECT System Market, by Segment, China (US$), 2007- 2013
- Exhibit 45: SPECT System Market, by Segment, China (CNY), 2007- 2013
- Exhibit 46: SPECT System Market Growth, by Segment, China, 2008- 2013
- Exhibit 47: Nuclear Medicine System Installed Base, by Segment, China,
2007- 2013
- Exhibit 48: Drivers and Limiters of the Nuclear Medicine System Market,
China
- Exhibit 49: Leading Competitors in the Nuclear Medicine System Market, as
a % of Total, China, 2008
APPENDIX B: SUPPLEMENTAL EXHIBITS
- Exhibit 50: Nuclear Medicine System Market, Global (US$), 2007- 2013
(Detailed Format)
- Exhibit 51: Nuclear Medicine System Market, by Segment, US (US$), 2007-
2013 (Detailed Format)
- Exhibit 52: Nuclear Medicine System Market, by Country, Europe (US$),
2007- 2013 (Detailed Format)
- Exhibit 53: Nuclear Medicine System Market, by Segment, China (US$), 2007-
2013 (Detailed Format)
|
 |
